← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2020Last known activity
May 19, 2025
Timeline
2010s
- Jun 1, 2019
Direct Biologics, LLC— Founded
Drugs by trial phase (4 distinct, 11 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (14)
- NCT04657458Lead sponsorN/A—
- NCT06918808Lead sponsorPhase 2May 19, 2025
- NCT05836883Lead sponsorPhase 1/Phase 2Aug 28, 2023
- NCT05836883Study directorPhase 1/Phase 2Aug 28, 2023
- NCT05176366Lead sponsorPhase 1Dec 19, 2022
- NCT05176366Study directorPhase 1Dec 19, 2022
- NCT05215288Lead sponsorEarly Phase 1Oct 31, 2022
- NCT05354141Lead sponsorPhase 3Jul 1, 2022
- NCT05130983Lead sponsorPhase 1Jan 1, 2022
- NCT05116761Lead sponsorPhase 1/Phase 2Dec 31, 2021
- NCT05127122Lead sponsorPhase 1/Phase 2Dec 31, 2021
- NCT05125562Lead sponsorPhase 2May 7, 2021
- NCT04493242Lead sponsorPhase 2Sep 1, 2020
- NCT04493242Reponsible party - principal investigatorPhase 2Sep 1, 2020
Details
- Founded
- Austin, TX, US Jun 1, 2019
- Last known activity
- May 19, 2025